Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
COVID-19
100%
Prognostic Significance
100%
Urinary Biomarkers
100%
Acute Kidney Injury
55%
Composite Outcome
33%
Kidney Outcomes
33%
Dialysis
11%
Prospective Cohort Study
11%
Inflammation
11%
Kidney Injury
11%
Kidney Injury molecule-1 (KIM-1)
11%
Kidney Disease Progression
11%
Serum Creatinine
11%
Poor Outcome
11%
Low Risk
11%
High Risk
11%
Small Sample Size
11%
Factor Level
11%
Academic Medical Centers
11%
Analytical Approach
11%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
11%
Epidermal Growth Factor
11%
Prognostic Information
11%
Cox Proportional Hazards Regression
11%
Patient-centered
11%
Hospital Admission
11%
Monocyte Chemoattractant protein-1 (MCP-1)
11%
Biomarker Combination
11%
Injury Biomarkers
11%
Kidney Biomarkers
11%
Disease Recovery
11%
Kidney Disease Improving Global Outcomes
11%
Subclinical Acute Kidney Injury
11%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Coronavirinae
100%
Diseases
100%
Acute Kidney Failure
54%
Kidney Disease
18%
Creatinine
9%
Inflammation
9%
Kidney Injury
9%
Disease Exacerbation
9%
Prospective Cohort Study
9%
Neutrophil Gelatinase Associated Lipocalin
9%
Kidney Injury Molecule 1
9%
Epidermal Growth Factor
9%
Monocyte Chemotactic Protein
9%